We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Consensus and Guidelines · January 27, 2021

Management of Psoriatic Disease During COVID-19

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2—Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments
J Am Acad Dermatol 2021 Jan 07;[EPub Ahead of Print], JM Gelfand, AW Armstrong, S Bell, GL Anesi, A Blauvelt, C Calabrese, ED Dommasch, SR Feldman, D Gladman, L Kircik, M Lebwohl, V Lo Re, G Martin, JF Merola, JU Scher, S Schwartzman, JR Treat, AS Van Voorhees, CT Ellebrecht, J Fenner, A Ocon, MN Syed, EJ Weinstein, G Gondo, S Heydon, S Koons, CT Ritchlin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading